Lotus Pharmaceutical Co., Ltd. (1795.TW)
TWD 260.5
(-1.14%)
TWD 260.5
(-1.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.62 Billion | 3.71 Billion | 119.66 Million | 1.94 Billion | 302.8 Million | 796.97 Million |
| Net Income | 4.1 Billion | 3.94 Billion | 1.87 Billion | 1.3 Billion | 876.42 Million | 163.7 Million |
| Depreciation & Amortization | 1.21 Billion | 936.86 Million | 759.38 Million | 709.62 Million | 586.69 Million | 391.53 Million |
| Deferred income taxes | -5.47 Billion | - | -69.11 Million | -166.68 Million | - | - |
| Stock-based compensation | 106.49 Million | 39.41 Million | 57.65 Million | 31.21 Million | - | - |
| Change in working capital | -3.43 Billion | -909.7 Million | -2.83 Billion | -299 Million | -1.33 Billion | 33.24 Million |
| Other non-cash items | 5.11 Billion | -287.36 Million | 334.9 Million | 369.29 Million | 173.62 Million | 208.49 Million |
| Investing Cash Flow | -3.25 Billion | -4.65 Billion | -1.57 Billion | -1.12 Billion | -2.38 Billion | -498.33 Million |
| Investments in PPE | -3.27 Billion | -3.06 Billion | -1.61 Billion | -1.99 Billion | -1.1 Billion | -399.06 Million |
| Acquisitions | 1.25 Million | 9.37 Million | 110 Thousand | 8.44 Million | -679.32 Million | 1.06 Million |
| Investment purchases | -43.48 Million | -1.6 Billion | 70.84 Million | 407.01 Million | -616.49 Million | - |
| Sales/Maturities of investments | 43.48 Million | -9.37 Million | 70.84 Million | 12.13 Million | 679.32 Million | - |
| Other Investing Activities | 14.45 Million | 18.86 Million | -102.89 Million | 445.1 Million | -669.04 Million | -99.27 Million |
| Financing Cash Flow | 1.4 Billion | 1.26 Billion | 1.66 Billion | -545.3 Million | 2.22 Billion | -958.12 Million |
| Debt repayment | -2.41 Billion | -5.27 Billion | -6.44 Billion | -3.58 Billion | -420 Million | -4.35 Billion |
| Dividends payments | -906.22 Million | -506.05 Million | -92 Million | - | - | - |
| Common Stock Repurchased | -108.31 Million | - | -57.35 Million | - | - | - |
| Common Stock Issuance | 598 Thousand | - | 1.41 Billion | - | 616.6 Million | - |
| Other Financing Activities | 4.83 Billion | 7.04 Billion | 6.84 Billion | 3.04 Billion | 2.02 Billion | 3.4 Billion |
| Accounts receivables | -1.66 Billion | -1.41 Billion | -637.81 Million | -361.01 Million | -1.14 Billion | 279.47 Million |
| Accounts payables | -659.57 Million | 648.39 Million | -980.98 Million | 996.45 Million | 132.84 Million | 315.36 Million |
| Inventory | -623.17 Million | -313.29 Million | -1.12 Billion | -1.09 Billion | -286.19 Million | -331.86 Million |
| Other working capital | -486.1 Million | 171.39 Million | -88.97 Million | 163.07 Million | -37.99 Million | 365.1 Million |
| Cash at beginning of period | 2.03 Billion | 1.6 Billion | 1.48 Billion | 1.27 Billion | 1.02 Billion | 1.77 Billion |
| Cash at end of period | 1.77 Billion | 1.98 Billion | 1.6 Billion | 1.48 Billion | 1.12 Billion | 1.02 Billion |
| Capital Expenditure | -3.27 Billion | -3.06 Billion | -1.61 Billion | -1.99 Billion | -1.1 Billion | -399.06 Million |
| Effect of forex changes on cash | 19.9 Million | 52.88 Million | -89.51 Million | -66.4 Million | -38.11 Million | -91.45 Million |
| Net cash flow / Change in cash | -261.17 Million | 377.88 Million | 116.49 Million | 212.13 Million | 101.48 Million | -750.94 Million |
| Free Cash Flow | -1.65 Billion | 650.02 Million | -1.49 Billion | -48.85 Million | -799.9 Million | 397.91 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.33 Billion | 1.3 Billion | 4.1 Billion | 399.95 Million | 1.56 Billion | 1.52 Billion |
| Depreciation & Amortization | 311.08 Million | 316.52 Million | 1.21 Billion | 323.06 Million | 292.44 Million | 294.53 Million |
| Deferred income taxes | - | - | -5.47 Billion | -724.53 Million | -200.59 Million | -782.45 Million |
| Stock-based compensation | 95.86 Million | 74.47 Million | 106.49 Million | 74.48 Million | 20.8 Million | 4.96 Million |
| Change in working capital | -703.35 Million | 112.01 Million | -3.43 Billion | -249.43 Million | -445.17 Million | -1.05 Billion |
| Other non-cash items | 1.33 Billion | 129.12 Million | 5.11 Billion | 195.03 Million | 125.47 Million | 204.06 Million |
| Investing Cash Flow | -265.5 Million | -398.61 Million | -3.25 Billion | -238 Million | -562.33 Million | -242.64 Million |
| Investments in PPE | -282.16 Million | -415.56 Million | -3.27 Billion | -344.21 Million | -574.03 Million | -273.47 Million |
| Acquisitions | 1.35 Million | - | 1.25 Million | 995 Thousand | 17 Thousand | 57 Thousand |
| Investment purchases | - | - | -43.48 Million | 64.51 Million | 62.72 Million | 1.46 Million |
| Sales/Maturities of investments | - | - | 43.48 Million | -64.51 Million | -17 Thousand | -57 Thousand |
| Other Investing Activities | 15.29 Million | 16.94 Million | 14.45 Million | 105.22 Million | -51.03 Million | 29.36 Million |
| Financing Cash Flow | -979.27 Million | -60.07 Million | 1.4 Billion | -28.7 Million | -568.72 Million | 139.67 Million |
| Debt repayment | -951.43 Million | -31.53 Million | -2.41 Billion | -4.67 Million | -31.57 Million | -7.87 Billion |
| Dividends payments | - | - | -906.22 Million | - | -906.22 Million | - |
| Common Stock Repurchased | - | - | -108.31 Million | - | - | - |
| Common Stock Issuance | 259 Thousand | - | 598 Thousand | - | 598 Thousand | - |
| Other Financing Activities | -28.1 Million | 47.3 Million | 4.83 Billion | -24.03 Million | 369.07 Million | 8.01 Billion |
| Accounts receivables | -674.4 Million | 336.15 Million | -1.66 Billion | -4.79 Million | -323.88 Million | -324.21 Million |
| Accounts payables | 91.87 Million | 21.48 Million | -659.57 Million | -93.68 Million | -240.54 Million | -162.52 Million |
| Inventory | -125.97 Million | -43.29 Million | -623.17 Million | 94.54 Million | -37.46 Million | -347.75 Million |
| Other working capital | 5.14 Million | -202.33 Million | -486.1 Million | -245.5 Million | 156.72 Million | -223.02 Million |
| Cash at beginning of period | 3.12 Billion | 1.77 Billion | 2.03 Billion | 2.05 Billion | 1.76 Billion | 1.66 Billion |
| Cash at end of period | 2.85 Billion | 3.12 Billion | 1.77 Billion | 1.77 Billion | 2.05 Billion | 1.76 Billion |
| Capital Expenditure | -282.16 Million | -415.56 Million | -3.27 Billion | -344.21 Million | -574.03 Million | -273.47 Million |
| Effect of forex changes on cash | 40.35 Million | 44.58 Million | 19.9 Million | -33.39 Million | 62.38 Million | 12.96 Million |
| Net cash flow / Change in cash | -265.08 Million | 1.35 Billion | -261.17 Million | -281.53 Million | 290.57 Million | 97.46 Million |
| Free Cash Flow | 657.18 Million | 1.34 Billion | -1.65 Billion | -325.65 Million | 785.22 Million | -86 Million |
TRENT
AMRUTANJAN
4222
SXTP
REDINGTON
1619